Loading insider details...
Latest Form 4 (Feb 26, 2026): Tax Withholding of 1,627 VRTX shares, $789.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,627 | $789.3K |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 4,962 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,903 | $928.2K |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 872 | $408.5K |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 3,934 | n/a |
| Nov 19, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 2,500 | $1.09M |
| Oct 30, 2025 | 89bio, Inc. (ETNB) | Disposition to Issuer | 20,000 | n/a |
| Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,482 | $1.19M |
| Feb 26, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,656 | $800.3K |
| Feb 19, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,529 | $708.6K |